Oral Antidiabetic Agents Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players and Applications Report 2021-2027

Report Summary

Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.
In 2020, the global Oral Antidiabetic Agents market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.

This report focuses on the global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Antidiabetic Agents development in United States, Europe and China.

The key players covered in this study
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla

Market segment by Type, the product can be split into
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors

Market segment by Application, split into
Home Use
Medical Institutions
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players.
To present the Oral Antidiabetic Agents development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oral Antidiabetic Agents are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table Of Contents

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type (2017-2027)
1.4.2 Sulfonylureas
1.4.3 Meglitinides
1.4.4 Biguanides
1.4.5 Thiazolidinediones
1.4.6 Alpha-glucosidase Inhibitors
1.5 Market by Application
1.5.1 Global Oral Antidiabetic Agents Market Share by Application (2017-2027)
1.5.2 Home Use
1.5.3 Medical Institutions
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Oral Antidiabetic Agents Market Size
2.2 Oral Antidiabetic Agents Growth Trends by Regions
2.2.1 Oral Antidiabetic Agents Market Size by Regions (2017-2027)
2.2.2 Oral Antidiabetic Agents Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Oral Antidiabetic Agents Market Size by Manufacturers
3.1.1 Global Oral Antidiabetic Agents Revenue by Manufacturers (2017-2020)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.2 Oral Antidiabetic Agents Key Players Head office and Area Served
3.3 Key Players Oral Antidiabetic Agents Product/Solution/Service
3.4 Date of Enter into Oral Antidiabetic Agents Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Oral Antidiabetic Agents Market Size by Type (2017-2020)
4.2 Global Oral Antidiabetic Agents Market Size by Application (2017-2020)

5 United States
5.1 United States Oral Antidiabetic Agents Market Size (2017-2020)
5.2 Oral Antidiabetic Agents Key Players in United States
5.3 United States Oral Antidiabetic Agents Market Size by Type
5.4 United States Oral Antidiabetic Agents Market Size by Application

6 Europe
6.1 Europe Oral Antidiabetic Agents Market Size (2017-2020)
6.2 Oral Antidiabetic Agents Key Players in Europe
6.3 Europe Oral Antidiabetic Agents Market Size by Type
6.4 Europe Oral Antidiabetic Agents Market Size by Application

7 China
7.1 China Oral Antidiabetic Agents Market Size (2017-2020)
7.2 Oral Antidiabetic Agents Key Players in China
7.3 China Oral Antidiabetic Agents Market Size by Type
7.4 China Oral Antidiabetic Agents Market Size by Application

8 Japan
8.1 Japan Oral Antidiabetic Agents Market Size (2017-2020)
8.2 Oral Antidiabetic Agents Key Players in Japan
8.3 Japan Oral Antidiabetic Agents Market Size by Type
8.4 Japan Oral Antidiabetic Agents Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Oral Antidiabetic Agents Market Size (2017-2020)
9.2 Oral Antidiabetic Agents Key Players in Southeast Asia
9.3 Southeast Asia Oral Antidiabetic Agents Market Size by Type
9.4 Southeast Asia Oral Antidiabetic Agents Market Size by Application

10 India
10.1 India Oral Antidiabetic Agents Market Size (2017-2020)
10.2 Oral Antidiabetic Agents Key Players in India
10.3 India Oral Antidiabetic Agents Market Size by Type
10.4 India Oral Antidiabetic Agents Market Size by Application

11 Central & South America
11.1 Central & South America Oral Antidiabetic Agents Market Size (2017-2020)
11.2 Oral Antidiabetic Agents Key Players in Central & South America
11.3 Central & South America Oral Antidiabetic Agents Market Size by Type
11.4 Central & South America Oral Antidiabetic Agents Market Size by Application

12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oral Antidiabetic Agents Introduction
12.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oral Antidiabetic Agents Introduction
12.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.2.5 Eli Lilly Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oral Antidiabetic Agents Introduction
12.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.3.5 Sanofi Recent Development
12.4 Roche
12.4.1 Roche Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oral Antidiabetic Agents Introduction
12.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.4.5 Roche Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oral Antidiabetic Agents Introduction
12.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.5.5 Teva Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oral Antidiabetic Agents Introduction
12.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.6.5 AstraZeneca Recent Development
12.7 Wockhardt UK
12.7.1 Wockhardt UK Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oral Antidiabetic Agents Introduction
12.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.7.5 Wockhardt UK Recent Development
12.8 Merck
12.8.1 Merck Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oral Antidiabetic Agents Introduction
12.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.8.5 Merck Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oral Antidiabetic Agents Introduction
12.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.9.5 Pfizer Recent Development
12.10 Cipla
12.10.1 Cipla Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oral Antidiabetic Agents Introduction
12.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2017-2020)
12.10.5 Cipla Recent Development

13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details